Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

british prostate group
(The British Prostate Group Spring Meeting, 16-17 March 2000, The
Prostate Cancer Prostatic Dis. 2000 Aug;3(2):120-129. Click here to read (The British Prostate Group Spring Meeting, 16-17 March 2000, The Swallow Royal

British Prostate Group Spring Meeting: 2nd and 3rd April 2001, The
Prostate Cancer Prostatic Dis. 2001;4(3):180-190. Click here to read British Prostate Group Spring Meeting: 2nd and 3rd April 2001, The Western Conference

British Library Direct: British Prostate Group BAUS Section of
Order from the British Library: British Prostate Group BAUS Section of Oncology British Uro-Oncology Group.

British Library Direct: British Prostate Group Spring Meeting 11th
Order from the British Library: British Prostate Group Spring Meeting 11th March 2004.

British Prostate Group
British Prostate Group. This page shows links to other items on the website. You can find things by:. looking at related sections of the website under the

British Prostate Group
British Prostate Group, British Prostate Group 10 May 2006 (49.6Kb 17sec @ 28.8Kbps). Adobe Acrobat reader required. Adobe Acrobat reader required.

Linkage analysis of chromosome 1q markers in 136 prostate cancer
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer

Charity summary | GuideStar UK
THE BRITISH PROSTATE GROUP. Official correspondence address from the Public Register of Charities: BAUS OFFICE 35-43 LINCOLN'S INN FIELDS LONDON WC2A 3PE

Charity organisation | GuideStar UK
The British Prostate Group ("the Group") is a registered charity and is governed by the rules and regulations set down in its constitution.

Metastasis Research Group
Putative tumour suppressor role for eplin and COM-1 in prostate cancer. Submitted to the British Prostate Group (BPG) meeting, September 2006, Cardiff.

BPG Home Page
Welcome to the British Prostate Group web site, The British Prostate Group (BPG) is a registered charity (charity number 1055115) established for the public

Prostate Cancer and Prostatic Diseases - Abstract of article
Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic British Prostate Group BAUS Section of Oncology British Uro-Oncology Group

Prostate Cancer and Prostatic Diseases - Abstract of article
BRITISH PROSTATE GROUP: SPRING MEETING AND TRAINING COURSE 2003. In conjunction with THE SCOTTISH CANCER FOUNDATION: Free Paper Presentations

South West Public Health Observatory - British Prostate Group
British Prostate Group Winter 2006: Changing case mix of prostate cancer patients in the South West. British Prostate Group Winter 2006: Changing case mix

South West Public Health Observatory - Resources - British
South West Public Health Observatory.

British Prostate Group
Prostate cancer (hormone-refractory) - docetaxel ยป; British Prostate Group British Prostate Group 10 May 2006 (49.58 Kb 14 sec)


british prostate group
erotic prostate milking
enlarge prostate treatment
cancer lupron prostate treatment
after radical prostatectomy